About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,492 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,492 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1041-1060 of 7,492 trials

Not yet recruitingStudy of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）This study is to evaluate the safety, and preliminary antitumor activity of TY-302 combined with Abiraterone tablets in patients with metastatic castration-resistant prostate…NCT07104617·Hangzhou, Zhejiang CompletedTreatment Preference and Patient Centered Prostate Cancer CareThe purpose of this study is to develop a preference based decision aid to assess the treatment preferences of prostate cancer patients, and to analyze the interaction of…NCT02032550·Philadelphia, Pennsylvania and 2 others CompletedRegistry and Database Lap ProstatectomyRecently, many centers have begun offering laparoscopic radical prostatectomy (LRP) as a minimally invasive therapy for localized prostate cancer.1-6 LRP may offer the advantages…NCT00169676·Indianapolis, Indiana UnknownA Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)For the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT)NCT00772317·Los Angeles, California and 15 others

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingA Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPCA single-center phase Ib/II dose escalation and dose-expansion clinical trial of REGN5678 plus cemiplimabNCT06826768·Houston, Texas

RecruitingSafety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate BrachytherapyThe purpose of this research study is to learn more about the outcomes and early and late side effects of treating early stage prostate cancer with high dose rate brachytherapy.NCT03424850·St Louis, Missouri

CompletedSentinel Lymph Node Detection in Prostate Surgery by LaparoscopyIn this study the investigators want to determine if the detection of lymph node is applicable in prostatectomy by laparoscopy.NCT01296217·Nantes

CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Prostate CancerThis study evaluates the safety and diagnostic performance of 18F-DCFPyL Injection in patients with at least high risk prostate cancer who are planned for radical prostatectomy…NCT02981368·San Francisco, California and 9 others

CompletedTranspelvic Magnetic Stimulation to Improve Urogenital FunctionAfter recruitment, 20 male patients will be assigned 1:1 to either age-matched control (G1: sham) or age-matched intervention (G2: pelvic magnetic stimulation; TPMS) groups using…NCT04488068·San Diego, California

CompletedImpact of Exercise on Mitochondria in Cancer Patients.The aim is to investigate the impact of prostate and colorectal cancer on mitochondrial quantity and quality along with muscle mass and function and whether this can be modified…NCT04558398·Derby, Derbyshire

CompletedBiomarkers of Androgen Response and Resistance In Evolution During a Rising PSAThis is an open-label phase 2 multi-center study of abiraterone and enzalutamide in men with castration-resistant prostate cancer. Sixteen patients will be enrolled over 18 months.NCT02429193·Vancouver, British Columbia and 1 other

CompletedTesting the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate GlandApalutamide is an anti-androgen that blocks the effect of testosterone on prostate cancer growth.NCT04530552·Tucson, Arizona and 4 others

Unknown177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate CancerThis is a pilot study to assess the safety and measure image-based absorbed dose of 177Lu-PSMA-EB-01, a new PSMA-specific radiopharmaceutical, in patients with metastatic…NCT05613738·Beijing, Beijing Municipality

Completedo Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate CancerDocetaxel is a standard chemotherapy for metastatic prostate cancer but is associated with dose-limiting peripheral neuropathy.NCT07333976·Taipei, Neihu

Active not recruitingProstate Cancer Monitoring Using [18F]DCFPyL and Blood Based BiomarkersPrimary Objective: * To determine whether changes in uptake of \[18F\]DCFPyL PET/CT scans at baseline and after 6 weeks of treatment for metastatic castrate resistant prostate…NCT03585114·New York, New York

TerminatedCureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceRegistry participants with advanced malignancy or myelodysplasia will have a sample of their tumor or tissue analysed for genetic alterations using next generation sequencing…NCT02900248·Idaho Falls, Idaho

CompletedUse of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)The main purpose of this study to determine the safety of an experimental medicine called 131I-MIP-1095.NCT03030885·New York, New York

CompletedProspective Multicentre Cohort Study PROREPAIR-B (mCRPC)PROREPAIR is a prospective multicenter observational cohort study of unselected patients with metastatic Castration Resistant Prostate Cancer (mCRPC) with unknown germline…NCT03075735

Active not recruitingProstate Advances in Comparative EvidenceThis study is an international multicentre randomised study of low, intermediate, and high risk prostate cancer and is composed of three parallel randomisation schemes based on…NCT01584258·Greater Sudbury, Ontario and 67 others

UnknownCabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)After failure on docetaxel, which has been the standard first line therapy for patients with metastatic castration-resistant prostate cancer (mCRPC), several treatment options are…NCT03050866·Delft and 8 others

PreviousPage 53 of 375Next